|
|
|
|
|
|
by xyhopguy
3075 days ago
|
|
|
can't say too much but I work on the stats side of liquid biopsy. Been in genomics (on the cs side) for the last 6 years. the encouring part to me is 1) we can predict the effect of a treatment given the tumors clonal composition, 2) we can test the effects of drugs much more quickly thx to crispr 3) easily profile a tumors composition with cfDNA. 1 and 3 imply we may be able to drive clonal evolution to a place where we can indefinitely treat patients. 2 gives us a lot more options. |
|
|